TC Biopharm ()

NASDAQ: TCBP · Real-Time Price · USD
0.50
0.00 (0.00%)
At close: Mar 21, 2025, 3:59 PM

TC Biopharm () Income Statement

Financials in GBP. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 3.84M 1.98M
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a 3.84M 1.98M
Operating Income
-14.24M -12.08M -7.29M
Interest Income
83.03K 6.75M 3.44M
Pretax Income
-7M -3.03M -14.98M
Net Income
-5.91M -1.31M -13.58M
Selling & General & Admin
6.87M 8.74M 3.11M
Research & Development
7.77M 7.59M 6.16M
Other Expenses
n/a n/a n/a
Operating Expenses
6.91M 124.9K 13.52M
Interest Expense
n/a 6.75M 3.44M
Selling & Marketing Expenses
402.31K 402.31K n/a
Cost & Expenses
6.91M 124.9K 13.52M
Income Tax Expense
-1.09M 1.72M 1.41M
Shares Outstanding (Basic)
617.84K 68.72K 39.06K
Shares Outstanding (Diluted)
617.84K 68.72K 39.06K
EPS (Basic)
-9.56 -19.12 -347.58
EPS (Diluted)
-9.56 -19.12 -347.58
EBITDA
-13.61M -11.32M -6.48M
EBIT
n/a 3.72M -11.54M
Depreciation & Amortization
630.06K 762.47K 811.96K